{
  "actions": [
    {
      "acted_at": "2012-05-24", 
      "references": [
        {
          "reference": "CR S3542-3543, S3547-3548, S3553-3554", 
          "type": "consideration"
        }
      ], 
      "text": "Amendment SA 2111 proposed by Senator Bingaman.", 
      "type": "action"
    }, 
    {
      "acted_at": "2012-05-24", 
      "how": "roll", 
      "references": [], 
      "result": "fail", 
      "roll": 105, 
      "text": "Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.", 
      "type": "vote", 
      "vote_type": "vote", 
      "where": "s"
    }
  ], 
  "amendment_id": "samdt2111-112", 
  "amendment_type": "samdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "s3187-112", 
    "bill_type": "s", 
    "congress": 112, 
    "number": 3187
  }, 
  "amends_treaty": null, 
  "chamber": "s", 
  "congress": "112", 
  "description": null, 
  "introduced_at": "2012-05-17", 
  "number": 2111, 
  "proposed_at": "2012-05-24", 
  "purpose": "To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive \"pay-for-delay\" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.", 
  "sponsor": {
    "district": null, 
    "name": "Bingaman, Jeff", 
    "state": "NM", 
    "thomas_id": "01285", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "fail", 
  "status_at": "2012-05-24", 
  "updated_at": "2013-07-19T20:24:16-04:00"
}